Unknown

Dataset Information

0

Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients.


ABSTRACT: Although functional rating scales are being used increasingly as primary outcome measures in spinal muscular atrophy (SMA), sensitive and objective assessment of early-stage disease progression and drug efficacy remains challenging. We have developed a game based on the Microsoft Kinect sensor, specifically designed to measure active upper limb movement. An explorative study was conducted to determine the feasibility of this new tool in 18 ambulant SMA type III patients and 19 age- and gender-matched healthy controls. Upper limb movement was analysed elaborately through derived features such as elbow flexion and extension angles, arm lifting angle, velocity and acceleration. No significant differences were found in the active range of motion between ambulant SMA type III patients and controls. Hand velocity was found to be different but further validation is necessary. This study presents an important step in the process of designing and handling digital biomarkers as complementary outcome measures for clinical trials.

SUBMITTER: Chen X 

PROVIDER: S-EPMC5266257 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients.

Chen Xing X   Siebourg-Polster Juliane J   Wolf Detlef D   Czech Christian C   Bonati Ulrike U   Fischer Dirk D   Khwaja Omar O   Strahm Martin M  

PloS one 20170125 1


Although functional rating scales are being used increasingly as primary outcome measures in spinal muscular atrophy (SMA), sensitive and objective assessment of early-stage disease progression and drug efficacy remains challenging. We have developed a game based on the Microsoft Kinect sensor, specifically designed to measure active upper limb movement. An explorative study was conducted to determine the feasibility of this new tool in 18 ambulant SMA type III patients and 19 age- and gender-ma  ...[more]

Similar Datasets

| S-EPMC9291175 | biostudies-literature
| S-EPMC4514700 | biostudies-other
| S-EPMC4393256 | biostudies-literature
| S-EPMC6638702 | biostudies-literature
| S-EPMC4713374 | biostudies-literature
| S-EPMC5094812 | biostudies-literature
| S-EPMC5678931 | biostudies-literature
| S-EPMC3002649 | biostudies-literature
| S-EPMC5802612 | biostudies-literature
| S-EPMC2527655 | biostudies-literature